Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 134 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1331 9.1 months Extensive-stage SCLC 5 Chemotherapy
University of California Davis Cancer Center United States 5/2010
Treatment Details: Patients: This phase III trial involved patients with extensive-stage small cell lung cancer (E-SCLC) that had not received previous therapy. Patients were divided into 2 separate treatmen
 
1332 9.0 months Ovarian cancer 4 Chemotherapy
Military Institute of the Health Services Poland 6/2009
Treatment Details: Patients: This study involved twenty-five women with heavily-pretreated ovarian cancer. The median age was 48, ranging from 46 to 52 years of age. Treatment: Patients were treated wit
 
1333 9.0 months Recurrent or persistant ovarian cancer 4 Chemotherapy
Sungkyunkwan University School of Medicine Korea 10/2009
Treatment Details: Patients: This phase 2 study involved 37 women with recurrent or persistent epithelial ovarian cancer. They had all received previous treatment for their cancer. The median age was 55, ran
 
1334 9.0 months Metastatic melanoma 5 Chemotherapy
Immunotherapy
Dana-Farber Cancer Institute United States 12/2008
Treatment Details: Patients: In this phase 3 study, patients with metastatic melanoma were divided into two separate treatment groups. Group 1 included 195 patients with a median age of 50.5 years and 75% ma
 
1335 9.0 months NSCLC 5 Chemotherapy
Errikos Dunant Hospital Greece 11/2010
Treatment Details: Patients: This phase 3 study involved patients with non-small-cell lung cancer. Patients were divided into two separate treatment groups. In group A, there were 114 patients, 104 of whom
 
1336 9.0 months colorectal (advanced) 5 Biologic therapy
Chemotherapy
NCI United States 7/2006
Treatment Details: Patients: This Phase II trial involved a total of 350 patients with advanced refractory colorectal cancer. This report focused on the initially planned cohort of 100 assessable patients. T
 
1337 9.0 months Advanced NSCLC 5 Chemotherapy
University of Kansas Medical Center United States 12/2005
Treatment Details: Patients: This Phase III study involved a total of 367 patients. Patients were divided into two groups: Group A had 181 patients and Group B had 186 patients. The median age for patients i
 
1338 9.0 months Advanced NSCLC 4 Chemotherapy
University of Kansas Medical Center United States 12/2005
Treatment Details: Patients: This Phase III study involved a total of 367 patients. Patients were divided into two groups: Group A had 181 patients and Group B had 186 patients. The median age for patients i
 
1339 9.0 months Advanced ovarian cancer 4 Chemotherapy
Errikos Dunant Hospital Greece 6/2007
Treatment Details: Patients: This study involved 45 women with advanced, previously treated ovarian cancer. The median age was 60, ranging from 39-82 years old. The majority (89%) had stage III disease, the
 
1340 9.0 months Newly diagnosed gliomas 4 Biologic therapy
Radiation
Dana-Farber Cancer Institute United States 9/2006
Treatment Details: Patients: This phase II study involved 12 children with newly diagnosed brain stem gliomas and 1 with glioblastoma multiforme. The median age was 6 years old, ranging from 2-14 years old.
 
Page 134 of 187  | Previous Page  | Next Page